Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Using Twitter to probe political polarization

  • Wobbly no more: Work on analogical processing helps children learn key engineering principle

  • How are ordinary consumers transforming the fashion business?

  • When are consumers more likely to rely on feelings to make decisions?

  • Saving money: Do consumers spend less if they think about the future?

  • Cultivating timeflow: Can consumers shape how they experience time?

  • Scientists one step closer to finding how to repair damaged nerve cells

  • Chronic loneliness in older adults leads to more doctors' office visits, study finds

  • Do consumers think products are better when companies donate to charity?

  • A matter of taste: When do products benefit from mixed reviews?

  •